Business Wire

VidMob Raises $50 Million Series C to Accelerate Broad Adoption of its Platform for Intelligent Creative

Share

VidMob, the leading platform for Intelligent Creative, announced today that it has closed its Series C financing, raising $50 million in expansion capital from a group of funds, strategic investors, and influential companies in the creative technology space. The new round will support VidMob’s global expansion, new e-commerce initiatives, ongoing investments into advanced technology, and data science to help marketers maximize the value of advertising creative.

The new round includes participation from Adobe, the global leader in digital creativity software, Shutterstock, a leading global creative platform offering full-service solutions, high-quality content, and tools for brands, businesses and media companies, Drive by DraftKings, a venture capital firm investing in sports tech and entertainment, the Spruce House Partnership, Prefix Capital, BuildGroup, Interlock Partners, Macanta, and key industry and tech leaders like Michael Kassan, Nick Brien, and Thomas Tull, among others. César Melo, former president at Mondelez and PepsiCo, CEO at Foster Grant and VP at Colgate-Palmolive is also investing and joining the board as an advisor. When combined with previous rounds, the company has now raised nearly $100 million to expand on its groundbreaking platform for Intelligent Creative.

VidMob has pioneered AI to measure creative performance so marketers can optimize ad design for more efficient and impactful campaigns. VidMob’s Intelligent Creative platform unifies creative and data and connects brands to a global network of elite content creators trained on continuously updated best practices for every digital media channel and next-gen ad format. Originally focused on partnerships with the major social platforms, VidMob has expanded its distribution to include leaders in the programmatic web and CTV / OTT.

“Every other area of enterprise operations has been positively impacted by software platforms -- increasing efficiency and using data to bring intelligence to decision-making,” said Alex Collmer, the founder and CEO of VidMob. “This financing and these new relationships will be a powerful accelerant in our commitment to build and deploy a platform that helps marketers transform for the needs of the future, while respecting the irreplaceable role of human creativity and never losing sight of our mission to evolve creativity for the better.”

“We were blown away by the power of VidMob’s learning models for Intelligent Creative,” said Owen Van Natta of Prefix Capital, and former VP of Worldwide Business and Corporate Development at Amazon. “VidMob’s ‘services-in-the-loop’ model, coupled with the integration of their creative marketplace is a construct that is unrivaled in its learning capability.”

“Creative performance has gone unmeasured while the advertising industry has focused on technologies to measure return on media spend, said Lynda Clarizio, former President of Nielsen US Media and an investor in the financing. “VidMob’s platform for Intelligent Creative solves this long unmet need by offering marketers a scalable platform across media to measure the impact of creative on achieving campaign objectives and to optimize and improve the creative process.”

Former Executive Vice-Chairman of Omnicom Media Group, and previously global CEO of OMD, Aegis Media and MEC, Mainardo de Nardis, who also invested in the financing, added, “I was privileged to be part of a group of people who transformed the full-service advertising model, separating media from creative, at a time when advertisers demanded independent strategic media services. That was 30 years ago. Today, I am happy to be doing the exact opposite. It no longer serves marketers well to silo creative and media practices, both equally important in terms of optimization. The power of VidMob’s data-driven platform lies in its ability to unite media and creative, bringing together the many layers of the industry, from advertising platforms and brands to agencies.”

Consumer brand veteran César Melo added "as a commercial leader, I was always looking to create a more efficient content ecosystem in which faster, smarter, data-informed and more cost-effective content could be created to surround the consumer around the world and build brands differently. When I discovered VidMob while trying to do this at PepsiCo, I was blown away by the combination of talented human creativity and technology. And the more I see, the more I like. VidMob is creating a new category, “Intelligent Creative.”

VidMob is the only company to have earned a creative partner badge from every leading social and digital media platform, and its client roster includes many of the world’s most forward-thinking marketing organizations such as Johnson & Johnson and Colgate Palmolive.

A purpose-driven company since Day 1, VidMob donates a portion of every dollar earned to fund Intelligent Creative for non-profit organizations through its 501c(3) VidMob Gives. VidMob Gives has supported 84 NPOs across 63 countries. In 2020, VidMob Gives helped raise over $20 million in partnership with organizations including the CDC Foundation, UN Foundation, Equality Now and the Ronald McDonald House.

About VidMob

VidMob is the world’s first platform for Intelligent Creative that provides an end-to-end solution to help brands improve their marketing results by unifying creative and data. VidMob is the only company in the world to receive a certified creative marketing partner badge from every major social and digital platform. A portion of every dollar VidMob receives is used to fund pro bono creative services for non-profits through its 501(c)(3) VidMob Gives. Most recently, the company was included in Inc. magazine's annual list of the Best Workplaces for 2020 and VidMob received the 2020 Creative Intelligence Technology Innovation Award from Frost & Sullivan. Learn more about VidMob at www.vidmob.com and VidMob Gives at vidmob.gives.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Tessa Flanagan
+44 (0)2036421124
Vidmob@teamgingermay.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection

Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release

Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played

Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release

At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will

Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release

Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w

MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release

MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye